| A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors (NCT04925947) | Weill Medical College of Cornell University | 2021-12-13 |
| KN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic Carcinoma (NCT04469725) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2020-12-02 |
| Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S (NCT04430842) | Quadriga Biosciences, Inc. | 2020-07-20 |
| Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVENT) (NCT03921671) | Claudia Proto | 2018-11-01 |
| Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors (NCT03583086) | Vanderbilt-Ingram Cancer Center | 2018-07-10 |
| A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors (NCT03517488) | Xencor, Inc. | 2018-07-10 |
| Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer (NCT03463460) | Dwight Owen | 2018-06-19 |
| Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM) (NCT03134118) | European Organisation for Research and Treatment of Cancer - EORTC | 2018-04-11 |
| A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy (NCT03076554) | National Cancer Institute (NCI) | 2017-04-19 |
| Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial) (NCT03449173) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2017-03-02 |
| Genomic Profiling of Nodular Thyroid Disease and Thyroid Cancer (NCT03170804) | Aventura Hospital and Medical Center | 2017-01-01 |
| A Study of Sunitinib in Patients With Metastatic or Recurrent Thymic Carcinoma (NCT02623127) | Seoul National University Hospital | 2015-10-01 |
| Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma (NCT02364076) | Georgetown University | 2015-03-01 |
| Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy (NCT02307500) | Istituto Clinico Humanitas | 2014-12-01 |
| Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy (NCT02062632) | Mayo Clinic | 2014-04-14 |
| Molecular Analysis of Thoracic Malignancies (NCT01385722) | Stanford University | 2011-08-01 |
| Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas (NCT01143545) | National Cancer Institute (NCI) | 2010-12-07 |
| Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma (NCT01011439) | Tiziana Life Sciences LTD | 2010-02-22 |
| Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma (NCT01025089) | Memorial Sloan Kettering Cancer Center | 2009-12-01 |
| Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy (NCT00965250) | National Cancer Institute (NCI) | 2009-08-01 |
| Paclitaxel and Cisplatin for Thymic Neoplasm (NCT00818090) | Korean Cancer Study Group | 2008-09-01 |
| Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage (NCT00589290) | National Cancer Institute (NCI) | 2007-12-01 |
| Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma (NCT00314873) | Indiana University | 2006-04-01 |
| Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma (NCT00198133) | Patrick Joseph Loehrer Sr. | 2005-01-01 |
| Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma (NCT00010257) | Eastern Cooperative Oncology Group | 2001-06-19 |
| Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases (NCT00003662) | Roswell Park Cancer Institute | 1998-08-01 |